Meanwhile, the LPS/TLR4 signaling pathway is primarily responsible for mediating the inflammatory response and pro-fibrogenic activity in numerous liver diseases, and studies have established that this route contributes to liver damage and fibrosis (Nobili et al., 2015; Mack, 2018; Unsal et al., 2021). The gene discussed is TLR4; the disease is liver disorder.